{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:32:37Z","timestamp":1789648357441,"version":"4.0.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.neuropharm.2024.110093","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T09:58:32Z","timestamp":1721987912000},"page":"110093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Activation of \u03bc receptors by SR-17018 through a distinctive mechanism"],"prefix":"10.1016","volume":"258","author":[{"given":"Samuel","family":"Singleton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9977-9012","authenticated-orcid":false,"given":"Clara","family":"Dieterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3600-1406","authenticated-orcid":false,"given":"David J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7090-1806","authenticated-orcid":false,"given":"Tyko","family":"Runeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9386-3030","authenticated-orcid":false,"given":"Andrew S.","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6467-1199","authenticated-orcid":false,"given":"Greta","family":"Rosenqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6815-5068","authenticated-orcid":false,"given":"Taylor","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuvam","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5358-1035","authenticated-orcid":false,"given":"Daniel","family":"Baptista-Hon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2040-9714","authenticated-orcid":false,"given":"Tim G.","family":"Hales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.110093_bib1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3390\/biom13060935","article-title":"Hyperactivity in mice induced by opioid agonists with partial intrinsic efficacy and biased agonism administered alone and in combination with morphine","volume":"13","author":"Acevedo-Canabal","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuropharm.2024.110093_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/17460441.2022.2008903","article-title":"Preclinical discovery and development of oliceridine (Olinvyk\u00ae) for the treatment of post-operative pain","volume":"17","author":"Azzam","year":"2022","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.neuropharm.2024.110093_bib3","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1111\/bph.15064","article-title":"Activation of \u03bc-opioid receptors by MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) and its fluorinated derivatives","volume":"177","author":"Baptista-Hon","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib4","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/35047086","article-title":"Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence","volume":"408","author":"Bohn","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2024.110093_bib5","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2024.110093_bib6","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/ALN.0000000000001834","article-title":"Src kinase inhibition attenuates morphine tolerance without affecting reinforcement or psychomotor stimulation","volume":"127","author":"Bull","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2024.110093_bib7","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(19)30430-1","article-title":"Perioperative opioid analgesia-when is enough too much? A review of opioid-induced tolerance and hyperalgesia","volume":"393","author":"Colvin","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2024.110093_bib8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1124\/mol.119.115956","article-title":"A biased view of \u03bc-opioid receptors?","volume":"96","author":"Conibear","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib9","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A G protein-biased ligand at the \u03bc-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine","volume":"344","author":"DeWire","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.110093_bib10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.bja.2020.06.057","article-title":"Antinociceptive, reinforcing, and pruritic effects of the G-protein signalling-biased mu opioid receptor agonist PZM21 in non-human primates","volume":"125","author":"Ding","year":"2020","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2024.110093_bib11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1476-5381.2011.01382.x","article-title":"Agonist-selective patterns of \u03bc-opioid receptor phosphorylation revealed by phosphosite-specific antibodies","volume":"164","author":"Doll","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib12","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.3390\/molecules26154509","article-title":"SR-17018 stimulates atypical \u03bc-opioid receptor phosphorylation and dephosphorylation","volume":"26","author":"Fritzwanker","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2024.110093_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainres.2008.04.036","article-title":"Pre-treatment with a PKC or PKA inhibitor prevents the development of morphine tolerance but not physical dependence in mice","volume":"1217","author":"Gabra","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110093_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaz3140","article-title":"Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists","volume":"13","author":"Gillis","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2024.110093_bib15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/mol.119.119214","article-title":"Intrinsic efficacy of opioid ligands and its importance for apparent bias, operational analysis, and therapeutic window","volume":"98","author":"Gillis","year":"2020","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41386-019-0491-8","article-title":"A G protein signaling-biased agonist at the \u03bc-opioid receptor reverses morphine tolerance while preventing morphine withdrawal","volume":"45","author":"Grim","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.110093_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/mol.106.028258","article-title":"An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization","volume":"71","author":"Groer","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib18","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1038\/s41386-021-01054-x","article-title":"Pharmacological and genetic manipulations at the \u03bc-opioid receptor reveal arrestin-3 engagement limits analgesic tolerance and does not exacerbate respiratory depression in mice","volume":"46","author":"He","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.110093_bib19","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/bph.14224","article-title":"The novel \u03bc-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception","volume":"175","author":"Hill","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib20","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1111\/bph.16199","article-title":"Assessment of the potential of novel and classical opioids to induce respiratory depression in mice","volume":"180","author":"Hill","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1124\/mol.112.082875","article-title":"Differentiation of opioid drug effects by hierarchical multi-site phosphorylation","volume":"83","author":"Just","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib22","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/bph.12222","article-title":"Efficacy and ligand bias at the \u03bc-opioid receptor","volume":"169","author":"Kelly","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev-pharmtox-052120-091058","article-title":"Biased agonism: lessons from studies of opioid receptor agonists","volume":"63","author":"Kelly","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib24","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1111\/bph.15004","article-title":"Morphine-induced respiratory depression is independent of \u03b2-arrestin2 signalling","volume":"177","author":"Kliewer","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41467-018-08162-1","article-title":"Phosphorylation-deficient G-protein-biased \u03bc-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects","volume":"10","author":"Kliewer","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2024.110093_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/pharmaceutics14010055","article-title":"Comparison of an addictive potential of \u03bc-opioid receptor agonists with G protein bias: behavioral and molecular modeling studies","volume":"14","author":"Kudla","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuropharm.2024.110093_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature10954","article-title":"Crystal structure of the \u03bc-opioid receptor bound to a morphinan antagonist","volume":"485","author":"Manglik","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2024.110093_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2024.110093_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0014-2999(99)00610-X","article-title":"Mu-opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S]GTP\u03b3S binding assays","volume":"383","author":"M\u00e1rki","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1124\/mol.110.066613","article-title":"\u03bc-opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization","volume":"78","author":"McPherson","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aas9609","article-title":"Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid \u03bc-opioid receptor desensitization","volume":"11","author":"Miess","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2024.110093_bib32","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.tips.2018.08.007","article-title":"Abuse potential of biased mu opioid receptor agonists","volume":"39","author":"Negus","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110093_bib33","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/dta.3238","article-title":"Investigation of the \u03bc- and \u03ba-opioid receptor activation by eight new synthetic opioids using the [35S]-GTP\u03b3S assay: U-47700, isopropyl U-47700, U-49900, U-47931E, N-methyl U-47931E, U-51754, U-48520, and U-48800","volume":"14","author":"Otte","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.neuropharm.2024.110093_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108439","article-title":"Comparison of morphine, oxycodone and the biased MOR agonist SR-17018 for tolerance and efficacy in mouse models of pain","volume":"185","author":"Pantouli","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.110093_bib35","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.3390\/molecules25204636","article-title":"Molecular modeling of \u03bc opioid receptor ligands with various functional properties: PZM21, SR-17018, morphine, and fentanyl-simulated interaction patterns confronted with experimental data","volume":"25","author":"Podlewska","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2024.110093_bib36","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in beta-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.110093_bib37","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1111\/bph.16084","article-title":"Carfentanil is a \u03b2-arrestin-biased agonist at the \u03bc opioid receptor","volume":"180","author":"Ramos-Gonzalez","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib38","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","article-title":"Bias factor and therapeutic window correlate to predict safer opioid analgesics","volume":"171","author":"Schmid","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2024.110093_bib39","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1113\/JP284003","article-title":"Morphine-induced mechanical hypersensitivity in mice requires \u03b4 receptors, \u03b2-arrestin2, and c-Src activity","volume":"601","author":"Singleton","year":"2023","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib40","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/bph.15409","article-title":"TRV130 partial agonism and capacity to induce anti-nociceptive tolerance revealed through reducing available \u03bc-opioid receptor number","volume":"178","author":"Singleton","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib41","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1124\/mol.114.096503","article-title":"A novel method for analyzing extremely biased agonism at G protein-coupled receptors","volume":"87","author":"Stahl","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102178118","article-title":"G protein signaling-biased mu opioid receptor agonists that produce sustained G protein activation are noncompetitive agonists","volume":"118","author":"Stahl","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2024.110093_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/adar.2022.10280","article-title":"Interaction with the lipid membrane influences fentanyl pharmacology","volume":"2","author":"Sutcliffe","year":"2022","journal-title":"Advances in Drug and Alcohol Research"},{"key":"10.1016\/j.neuropharm.2024.110093_bib44","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00204-021-03207-9","article-title":"Characterization of recent non-fentanyl synthetic opioids via three different in vitro \u03bc-opioid receptor activation assays","volume":"96","author":"Vandeputte","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib45","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1111\/bph.14702","article-title":"The G-protein-biased agents PZM21 and TRV130 are partial agonists of \u03bc-opioid receptor-mediated signalling to ion channels","volume":"176","author":"Yudin","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110093_bib46","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1016\/j.cell.2022.09.041","article-title":"Molecular recognition of morphine and fentanyl by the human \u03bc-opioid receptor","volume":"185","author":"Zhuang","year":"2022","journal-title":"Cell"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824002624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824002624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T19:08:40Z","timestamp":1738609720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824002624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":46,"alternative-id":["S0028390824002624"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110093","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of \u03bc receptors by SR-17018 through a distinctive mechanism","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110093"}}